The Valley Desk

Clinical trial reportJournal of neuro-oncologyPublished

Phase I study targeting newly diagnosed grade 4 astrocytoma with bispecific antibody armed T cells (EGFR BATs) in combination with radiation and temozolomide

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names The Wistar Institute. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of neuro-oncology
Published
Subject terms
Leukocytes, Mononuclear; T-Lymphocytes; Humans; Glioblastoma; Brain Neoplasms; Antineoplastic Agents, Alkylating; ErbB Receptors; Temozolomide; EGFR; immune therapy; Phase I; Bispecific Antibodies
PubMed ID
38263486
PubMed Central ID
PMC10834565
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal